Inovio Pharmaceuticals, Inc. Gains 30.92%
Thu, Jun 25, 2020 at 05:34 PM
Inovio Pharmaceuticals, Inc. (INO:NASDAQ) soared at $31.25, representing a gain of 30.9%. On Wed 24 Jun 20, INO:NASDAQ touched a New 2-Week High of $23.87. The stock appeared on our News Catalysts scanner on Thu 25 Jun 20 at 02:06 PM in the 'MISCELLANEOUS' category. From Wed 10 Jun 20, the stock recorded 60.00% Up Days and 72.73% Green Days
About Inovio Pharmaceuticals, Inc. (INO:NASDAQ)
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
Top 10 Gainers:
- Professional Diversity Network, Inc. (IPDN:NASDAQ), 142.76%
- Ekso Bionics Holdings, Inc. (EKSO:NASDAQ), 135.32%
- Puhui Wealth Investment Management Co., Ltd. (PHCF:NASDAQ), 105.79%
- Vaxart, Inc. (VXRT:NASDAQ), 96.24%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 55.83%
- Kitov Pharma Ltd (KTOV:NASDAQ), 46%
- Ocean Bio-Chem, Inc. (OBCI:NASDAQ), 39.13%
- PaySign, Inc. (PAYS:NASDAQ), 37.13%
- Sino-Global Shipping America, Ltd. (SINO:NASDAQ), 33.31%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 30.92%